Publications
281 publications
Sort by: Date / Relevance
GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis
Zorginstituut Nederland has completed its assessment whether romosozumab (Evenity®) is interchangeable with a product that is ...
GVS assessment - extension of further conditions for nintedanib (Ofev®)
Zorginstituut Nederland has completed its assessment of the possible extension of the further conditions for nintedanib (Ofev®) ...
Package advice polatuzumab vedotin (Polivy®) in combination with bendamustine and rituximab (Pola-BR) for the treatment of r/r DLBCL
Zorginstituut Nederland has completed its assessment whether polatuzumab vedotin (Polivy®) in combination with bendamustine and ...
GVS assessment of tafamidis (Vyndaqel®) for the treatment of wild-type or hereditary transthyretin amyloidosis
Zorginstituut Nederland has completed its assessment whether tafamidis (Vyndaqel®) for the treatment of wild-type or hereditary ...
Package advice venetoclax (Venclyxto®) in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)
Zorginstituut Nederland has completed its assessment whether venetoclax (Venclyxto®) in combination with obinutuzumab for the ...
GVS assessment of glucagon nasal powder (Baqsimi®) for the treatment of severe hypoglycaemia
Zorginstituut Nederland has completed its assessment whether glucagon nasal powder (Baqsimi®) for the treatment of severe ...
GVS assessment of ozanimod (Zeposia®) for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS)
Zorginstituut Nederland has completed its assessment whether ozanimod (Zeposia®) for the treatment of adult patients with ...
Package advice esketamine nasal spray (Spravato®) for the treatment of adults with treatment-resistant major depressive disorder
Zorginstituut Nederland has completed its assessment whether esketamine nasal spray (Spravato®) can be included in the insured ...
Trastuzumab-emtansine (Kadcyla®) in adjuvant treatment of adult patients with HER-2 positive breast cancer in an early stage
Zorginstituut Nederland has completed its assessment whether trastuzumab-emtansine (Kadcyla®) can be included in the insured ...
Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) for maintenance treatment of asthma in adult patients
Zorginstituut Nederland has completed its assessment whether Indacaterol/glycopyrronium/mometasone (Enerzair® Breezhaler®) can be ...